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Abstract	47 
	48 
Background	49 
In	2013,	200	million	tourists	visited	countries	that	are	endemic	for	hepatitis	B	virus	(HBV).	50 
Backpackers	are	potentially	at	greater	risk	of	hepatitis	B	than	other	travellers	yet	exposure	to	51 
HBV	remains	under	researched	in	this	population.		52 
Method	53 
A	cross-sectional	survey	of	backpackers	visiting	two	islands	in	Thailand	was	performed	during	54 
early	2015.		Participation	in	activities	with	high	HBV	exposure	risk	was	recorded,	alongside	55 
rates	of	vaccination	and	an	evaluation	of	knowledge	and	attitudes	towards	the	risk	of	HBV.	56 
Results	57 
1680	 questionnaires	 were	 completed	 and	 analysed;	 the	 median	 participant	 age	 was	 24	58 
(range:	18-68)	and	47.9%	were	male.	 	20.8%	took	part	 in	activities	with	a	high	risk	of	HBV	59 
exposure.	Over	two-thirds	of	the	sample	were	not	protected	against	HBV.	24%	were	able	to	60 
correctly	 identify	 HBV	 transmission	 methods.	 44.1%	 underestimated	 the	 risk	 of	 HBV	 in	61 
Thailand.		62 
Conclusions	63 
The	proportion	of	backpackers	participating	in	high-risk	activities	was	double	the	level	found	64 
in	previous	studies	that	have	examined	the	HBV	exposure	risk	amongst	travellers	to	endemic	65 
countries.	Voluntary	risk	activities	were	the	largest	source	of	potential	exposure	to	HBV	and	66 
rates	of	vaccination	are	low.	Backpackers	should	be	considered	for	routine	vaccination	and	67 
education	on	risk	behaviours	should	be	included	in	the	pre-travel	consultation.			68 
	69 
	70 
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	72 
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Hepatitis	B:	a	cross-sectional	survey	of	knowledge,	attitudes	and	practices	amongst	75 
backpackers	in	Thailand	76 
1.1	Introduction	77 
Hepatitis	B	is	a	viral	infection	that	can	cause	a	spectrum	of	liver	disease	including	acute	78 
illness	and	long-term	complications	[1].	The	heaviest	burden	of	diseases	is	in	Asia	and	Sub-79 
Saharan	Africa	 [2].	 	A	vaccine	 for	hepatitis	B	virus	 (HBV)	has	been	available	 since	1986;	 it	80 
reduces	rates	of	hepatitis	after	exposure	and	is	ninety-five	per	cent	effective	at	preventing	81 
chronic	carriage	of	HBV	[3].		HBV	is	one	of	the	commonest	vaccine-preventable	diseases	in	82 
travellers	[4].	Since	the	1950s,	international	tourism	has	shown	almost	uninterrupted	growth:	83 
the	fastest	growing	destination,	South	East	Asia,	 is	a	high	HBV	endemicity	region	[5,6].	 	 In	84 
2013,	200	million	tourists	visited	countries	where	more	than	five	per	cent	of	the	population	85 
are	 chronic	 carriers	 of	HBV	 [5,6].	 	 Travellers	 from	 countries	with	 low	HBV	prevalence	 are	86 
particularly	at	risk	as	either	vaccination	or	previous	infection	is	required	for	immunity.		87 
HBV	is	transmitted	by	contact	with	infected	blood	or	bodily	fluids	either	through	the	88 
skin	 (percutaneous)	 or	 through	mucosal	 membranes	 (transmucosal).	 	 Infection	 by	 sexual	89 
contact,	contaminated	medical	or	dental	equipment	and	skin	penetrating	procedures	occurs	90 
in	all	 intermediate	and	high	prevalence	countries	[2,7].	 	Hepatitis	B	presents	a	risk	both	to	91 
non-immune	travellers	and,	on	returning	home,	to	their	close	contacts	[8].		The	World	Health	92 
Organisation	 (WHO)	 has	 recommended	 universal	 vaccination	 against	 HBV	 since	 1992	 but	93 
some	 western	 countries,	 including	 the	 United	 Kingdom	 (UK),	 have	 opted	 for	 selective	94 
vaccination	strategies	based	on	individual	risk	factors	[9].		Vaccination	for	travel	is	not	routine:	95 
the	Department	of	Public	Health	England	suggests	a	decision	should	be	made	depending	on	96 
the	 duration	 of	 travel,	 planned	 activities	 and	 the	 destination’s	 HBV	 prevalence	 [10].		97 
Vaccination	is	expensive	and	usually	paid	for	by	the	individual	[11].	98 
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Backpackers	are	a	distinct	subset	of	international	travellers;	they	typically	travel	for	99 
longer	 durations,	 alone	 or	 in	 small	 groups	 and	 stay	 in	 low-cost	 accommodation	 [12].	 	 As	100 
backpackers	are	 typically	younger	 than	other	 travellers	 they	are	 less	 risk-averse	and	more	101 
likely	to	engage	in	adventurous	activities	[12].		These	factors	combined	place	them	at	greater	102 
risk	 of	 contracting	 hepatitis	 B	 than	 other	 travellers,	 yet	 exposure	 to	 HBV	 remains	103 
underresearched	 in	 this	population.	 	Thailand	 is	a	popular	backpacker	destination	and	the	104 
WHO	classifies	the	country	as	having	‘intermediate-high’	HBV	prevalence,	as	5-6%	of	adults	105 
are	chronic	carriers	[6].	106 
This	 study	aims	 to	determine	 the	proportion	of	backpackers	 visiting	 two	 islands	 in	107 
Thailand	 who	 are	 at	 high	 risk	 of	 HBV	 exposure	 and	 identify	 the	 factors	 associated	 with	108 
exposure,	immunisation	and	seeking	pre-travel	health	advice.		109 
1.2	Method	110 
1.2.1	Design		111 
Cross	sectional	survey		112 
1.2.2	Setting	113 
The	 research	 was	 conducted	 at	 the	 ferry	 ports	 of	 two	 islands,	 which	 are	 popular	 with	114 
backpackers:	Ban	Mae	Haad,	Koh	Tao	and	Thong	Sala,	Koh	Phangan	in	Thailand.	115 
1.2.3	Participants		116 
Backpackers,	defined	as	travellers	on	a	limited	budget,	staying	in	low	cost	accommodation	117 
and	carrying	their	belongings	in	a	backpack	[12],	who	were	able	to	understand	spoken	and	118 
written	English,	were	recruited	for	the	survey.		Thai	nationals	were	excluded	as	data	suggest	119 
that	tourists	on	domestic	vacations	behave	differently	to	those	on	 international	trips	 [13].	120 
Individuals	 who	 lacked	 capacity	 or	 were	 under	 18	 years	 of	 age	 were	 also	 excluded.	 	 In	121 
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accordance	with	the	University	of	Birmingham’s	policies,	US	citizens	were	excluded	from	the	122 
survey.		123 
1.2.4	Data	Collection	124 
Data	 were	 collected	 during	 February	 and	 March	 2015.	 Participants	 were	 recruited	 using	125 
convenience	sampling	[14]:	two	researchers	(GF	&	EM)	approached	travellers,	in	possession	126 
of	a	backpack,	who	were	waiting	to	board	outward-bound	ferries.		The	study	was	explained	127 
and	 if	 the	 participant	 self-defined	 as	 a	 backpacker	 –	 ‘an	 individual	 travelling	 on	 a	 limited	128 
budget	and	staying	 in	 low	cost	accommodation’	-	and	met	the	 inclusion	criteria	they	were	129 
invited	to	take	part	in	the	study.	No	cut-offs	were	used	to	define	a	limited	budget	or	low-cost	130 
accommodation.	Participants	were	provided	with	an	information	sheet	and	questionnaire	to	131 
complete	and	return	to	the	researcher.	Ethical	approval	 for	the	study	was	sought	from	an	132 
Internal	 Ethics	 Committee	 at	 the	 University	 of	 Birmingham	 (Reference	 number:	 2014-133 
15/C1/LJ/05).	134 
1.2.5	Instruments		135 
The	questionnaire	consisted	of	four	sections,	(i)	demographic	data	(ii)	pre-travel	health	advice	136 
(iii)	health	problems	and	health	service	usage	(iv)	HBV	knowledge,	attitudes	and	practices.	137 
Section	(iii)	data	relate	to	a	study	conducted	by	another	University	of	Birmingham	student.			138 
Protection	against	HBV	was	classified	as	having	completed	a	vaccination	schedule	(3	139 
or	more	doses)	or	reporting	a	previous	HBV	 infection	[15].	Potential	exposure	to	HBV	was	140 
assessed	by	asking	the	participants	if	they	had	taken	part	in	risky	activities	classified	as	‘low’	141 
and	 ‘high’	 risk;	 high-risk	 activities	 involved	 skin	perforation	or	unprotected	 sexual	 contact	142 
whilst	 low	 risk	 activities	 were	 documented	 transmission	 routes	 that	 did	 not	 involve	 skin	143 
perforation	or	unprotected	sexual	contact	(Table	1)	[16].		144 
Table	1.		
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Classification	of	‘risky	activities’	
Risk	Level	 Activity	
High	 Tattoo;	Piercing;	Unprotected	sex;	Medical	treatment	(stitches,	injections,	surgery,	blood	transfusion,	acupuncture);	Dental	treatment;	Injecting	drugs	
Low	 Manicure/Pedicure;	Barbershop	shave;	Attending	a	bleeding	individual	
	145 
1.2.6	Data	Analysis	146 
Data	were	analysed	using	IBM	SPSS	Statistics	v22	(IBM	Corp,	Armonk,	NY,	USA);	the	147 
demographic	data	were	examined	and	the	sample	characteristics	presented.	The	median	age	148 
was	presented	as	the	distribution	was	positively	skewed.	The	proportions	of	participants	who	149 
had	participated	 in	high	HBV	 risk	activities	and	 reported	completed	vaccination	 schedules	150 
against	 HBV	 (3	 or	 more	 doses)	 were	 calculated.	 Binary	 logistic	 regression	 identified	151 
associations	 between	 exposure	 or	 completed	 vaccination	 schedule	 and	 the	 pre-selected	152 
variables	(Table	2).	Knowledge	scores	were	calculated	by	awarding	one	mark	per	correctly	153 
answered	 question	 and	 making	 a	 total	 score	 (range	 0-9).	 The	 median	 total	 score	 was	154 
calculated,	as	the	data	were	not	normally	distributed.			155 
Table	2.	
Variables	selected	for	binary	logistic	regression	analysis	of	exposure	and	having	completed	a	vaccination	schedule	
Nominal	variable																																																										Measurement	variables	
Exposure	
Age,	gender,	travelling	alone,	travelling	with	a	sexual	partner,	planned	trip	duration,	duration	
so	far,	sought	pre-travel	advice,	knowledge	score,	protection	against	HBV,	perceived	HBV	risk	
to	self	and	underestimate	of	HBV	risk	in	Thailand	
Completed	
vaccination	
schedule	
Age,	gender,	planned	trip	duration,	pre-travel	advice,	knowledge	score,	perception	of	risk	to	
self	and	whether	they	believe	vaccination	is	effective	
	156 
1.3	Results	157 
Of	 the	 1825	 individuals	 who	 consented	 to	 take	 part	 and	 completed	 the	 survey,	 the	158 
questionnaires	 from	 1680	 participants	 were	 usable	 and	 analysed	 (Fig.	 1	 Recruitment	159 
Flowchart).	The	median	age	of	the	sample	was	24	years	(IQR	6;	Range	18-68),	802	(47.9%)	160 
were	male.	1325	 (79.5%)	of	 the	sample	were	residents	of	Europe,	239	 (14.3%)	were	 from	161 
Canada,	Australia	and	New	Zealand.	The	remaining	6%	was	made	up	of	residents	from	South	162 
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America,	Africa	and	Asia.	The	demographic	characteristics	of	the	sample	are	shown	in	Table	163 
3.		164 
	165 
	166 
	167 
	168 
	169 
	170 
	171 
	172 
	173 
	174 
Table	3	
Participant	Demographics	
	 	 n	(%	of	total)	
Figure	1.	Recruitment	Flowchart		
2510 Individuals 
Approached
Refused: 206 Excluded: 479
Non-Backpacker: 286 
Non-English Speaking: 135
American: 55 
Thai: 2 
U18: 1 
1825 Participants 
Consented
Excluded*: 22
Unusable+: 123
Questionnaires 
Analysed: 1680
*US	citizen	(n=15),	Under	18	years	(n=3),	Thai	national	(n=4)	
+Due	to	corruption	of	electronically	stored	data	files		
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Age	Group	 18-24	years	 955	(56.8)	
	 25-34	years	 651	(38.8)	
	 >35	years	 63	(3.8)	
Gender	(Male)	 802	(47.9)	
Planned	Trip	Duration	 <	1	month	 591	(35.3)	
	 >1-3	months	 600	(35.9)	
	 >3-6	months	 270	(16.1)	
	 >6-12	months	 136	(8.1)	
	 >1	year	 76	(4.5)	
Trip	duration	so	far	 <	2	weeks	 310	(18.5)	
	 2	-	4	weeks		 689	(41.0)	
	 4	-	8	weeks	 408(24.3)	
	 >8	weeks	 232	(13.8)	
Visiting	other	countries	in	SE	Asia	 907	(54)	
Travel	Group	 Alone	 262	(15.8)	
	 Pair	 902	(54.6)	
	 Group	 489	(29.6)	
Travelling	with	a	sexual	partner	 515	(31.3)	
Total	=	1680	
	175 
1.3.1	Pre-travel	preparation		176 
Pre-travel	health	advice	was	sought	by	1346	(80.1%)	of	participants;	the	most	popular	source	177 
of	pre-travel	information	was	the	Internet	followed	by	relatives/friends.	Of	the	1202	(71.5%)	178 
participants	who	answered	the	questions	concerning	topics	of	advice	received	from	a	health	179 
care	 professional,	 761	 (63.3%)	 recalled	 receiving	 information	 of	 HBV	 risk	 factors	 and	 835	180 
(69.5%)	recalled	receiving	advice	about	the	HBV	vaccine.	181 
1.3.2	Knowledge	of	HBV	182 
The	median	knowledge	score	was	5	(IQR=4)	out	of	a	total	possible	score	of	9;	these	questions	183 
were	answered	by	1592	 (94.8%)	of	 the	1680	participants.	370	 (24%)	participants	correctly	184 
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answered	that	HBV	can	be	transmitted	by	blood	and	sexual	contact	but	not	by	contaminated	185 
food	and	water	or	toilet	visits.	 186 
1.3.3	Attitudes	towards	HBV	187 
When	asked	to	estimate	the	risk	of	HBV	in	Thailand,	740	(44.1%)	participants	either	188 
did	not	know	or	considered	the	risk	to	be	low.	510	(30.4%)	participants	considered	themselves	189 
to	be	at	risk	of	HBV	whilst	632	(37.1%)	did	not	considered	themselves	at	risk,	the	remainder	190 
were	unsure.	The	majority	of	participants	considered	vaccination	to	be	effective	at	preventing	191 
infection,	while	24.5%	were	unsure	whether	it	was	effective.		192 
1.3.4	Practices:	Exposure	Risk	and	Immunisation		193 
332	(20.8%)	participants	took	part	in	one	or	more	activity	with	a	high	HBV	exposure	194 
risk	(Table	4).	381	(22.7%)	participants	reported	taking	part	in	an	activity	with	a	low	associated	195 
exposure	risk. 1010	(60%)	of	the	sample	did	not	report	a	high	or	low	risk	activity.	196 
Table	4.		
Participation	in	activities	with	an	HBV	exposure	risk	 	
Exposure	Level	 Risk	Activity	 																		n	(%)	
Low	
Manicure/pedicure	 244	(14.5)	
Barbershop	shave	 100	(6.0)	
Attended	a	bleeding	individual	 69	(4.1)	
High	
Body	Modification+	 131	(7.8)	
Medical	or	Dental	Treatment*	 85	(5.1)	
Injected	drugs	 27	(1.6)	
Had	sex	with	someone	other	than	a	regular	partner	 353	(22.7)	
Did	not	always	use	a	condom	 153	(9.8)	
Paid	for	sex	 47	(3.5)	
Did	not	always	use	a	condom	 13	(1.0)	
Percentages	may	not	add	up	to	100	due	to	missing	data.	+Body	Modification	encompasses	tattoos	and	
piercings.	*Medical	treatment	includes	surgery,	blood	transfusions,	injections,	and	acupuncture	and	
stitches.	Participants	can	select	multiple	answers.	
	197 
HEPATITIS B: KAP AMONGST BACKPACKERS IN THAILAND   10 
Of	the	1277	individuals	reporting	vaccination	against	HBV,	397	(31.1%)	had	completed	198 
the	schedule	(three	or	more	doses)	whilst	561	(43.9%)	had	received	either	one	or	two	doses;	199 
319	(25%)	did	not	know	how	many	doses	they	had	received.	504	(30.0%)	of	the	sample	were	200 
protected	against	HBV	(previous	infection	or	three	or	more	vaccine	doses).		201 
1.3.5	Factors	associated	with	high	exposure	risk	202 
In	a	binary	logistic	regression	model	the	pre-selected	variables	explained	13%	of	the	203 
variability	in	the	data	(Nagelkerke	R2=0.13)	and	correctly	predicted	7.2%	(n=22)	of	individuals	204 
who	reported	a	high	exposure	risk.	Gender,	age,	‘planned	trip	duration	<1	month’	and	‘total	205 
duration	so	far’	were	significantly	associated	with	high	exposure	risk.	The	adjusted	odds	ratios	206 
are	presented	in	Table	5.		207 
Table	5.		
Adjusted	Odds	Ratios	for	Variables	Associated	with	High	HBV	Exposure	Risk	
	
HBV	Exposure	Level	 	 	
High	
n=332	
Low	or	None	
n=1266	
	 	
n	(%)	 n	(%)	 OR	(95%	CI)	 Sig.	
Median	participant	age	(years)	 23	 24	 0.94	(0.90-0.97)	 0.001*	
Gender	
Male	 186	(56.0)	 568	(44.9)	 1.0	(ref)	 	
Female	 143	(43.1)	 695	(54.9)	 0.61	(0.47-0.80)	 <.001*	
Duration	of	trip	
<	1	month	 64	(19.3)		 501	(39.6)	 0.45	(0.22-0.92)	 <.001*	
>	1	month	 264	(79.5)	 793	(62.6)	 1.0	(ref)	 	
		Median	duration	so	far	(weeks)	 4.0	 3.0	 1.03	(1.02-1.04)	 <.001*	
Percentages	may	not	add	up	to	100	due	to	missing	data.		
	1.3.6	Factors	associated	with	completed	vaccination	208 
In	a	binary	logistic	regression	model	the	pre-selected	variables	explained	4.6%	of	the	209 
variability	 in	 the	 data	 and	 did	 not	 predict	 any	 of	 the	 individuals	 who	 had	 completed	 a	210 
vaccination	course.		211 
1.3.7	Visiting	a	travel	clinic	or	family	doctor/nurse	212 
Participants	who	reported	visiting	a	travel	clinic	or	family	doctor/nurse	as	part	of	their	213 
pre-travel	health	advice	had	significantly	higher	knowledge	scores	than	individuals	who	had	214 
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used	other	sources	of	pre-travel	health	advice	(Mann-Whitney	U:	165681;	r=-0.09;	p=0.001).	215 
There	 was	 no	 statistical	 difference	 in	 participation	 in	 high	 HBV	 exposure	 risk	 activities	216 
between	individuals	who	had	visited	a	travel	clinic	or	their	family	doctor/nurse	and	those	who	217 
had	sought	pre-travel	health	advice	elsewhere	(Χ²	(1,	n=1285)	=	0.66;	p=.418).			218 
1.4	Discussion	219 
1.4.1	Main	Findings	220 
One	in	five	backpackers	had	participated	in	a	high	exposure	risk	activity	during	their	221 
travels.	 Two-thirds	 of	 the	 sample,	which	participated	 in	 high	HBV	exposure	 risk	 activities,	222 
reported	no	protection	against	HBV.	There	was	no	association	between	participation	in	high-223 
risk	 activities	 and	protection	against	HBV.	 Four	 variables	were	 found	 to	be	 independently	224 
associated	 with	 high	 exposure	 risk	 but	 the	 model	 explained	 only	 a	 small	 amount	 of	 the	225 
variability	in	the	data,	suggesting	that	other	factors	may	also	play	a	role	in	high-exposure	risk.	226 
In	 the	 present	 study,	 over	 40%	 of	 participants	 reporting	 vaccination	 had	 not	227 
completed	 the	 vaccination	 schedule,	 which	 requires	 three	 doses	 over	 six	 months	 or	 an	228 
accelerated	course	of	three	doses	over	two	months	[10].	23.6%	of	participants	had	completed	229 
a	HBV	vaccination	schedule	(3	or	more	doses).		230 
Over	half	of	the	sample	had	visited	a	travel	clinic	or	their	family	doctor/nurse	prior	to	231 
departure:	this	was	associated	with	higher	knowledge	scores	but	was	not	associated	with	any	232 
reduction	in	high-risk	exposure.	More	than	60%	of	participants	who	had	received	advice	from	233 
a	 health	 care	 professional	 reported	 being	 informed	 about	 HBV	 risk	 factors	 and	 given	234 
information	about	the	vaccine.		235 
1.4.2	Comparison	with	previous	literature	236 
The	proportion	of	backpackers	who	participated	in	high-risk	activities,	whilst	visiting	237 
the	two	islands	of	Thailand,	was	double	the	level	found	in	previous	studies	examining	HBV	238 
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exposure	risk	amongst	travellers	to	endemic	countries	[8,17,18].	Unforeseen	medical	care	has	239 
previously	been	identified	as	the	largest	source	of	potential	HBV	exposure	whilst	travelling	240 
[19]	but	in	this	study,	voluntary	risk	activities	were	the	largest	source	of	potential	exposure	241 
to	HBV:	9.5%	of	participants	reported	having	unprotected	sex	and	7.8%	reported	a	tattoo	or	242 
piercing	whilst	abroad.	The	proportion	of	backpackers	at	risk	of	HBV	as	a	result	of	requiring	243 
medical	 or	 dental	 treatment	 (5.1%)	 is	 similar	 to	 that	 found	 in	 studies	 of	 other	 groups	 of	244 
travellers	[8,17,19].	245 
Four	out	of	five	participants	reported	seeking	pre-travel	health	advice:	this	 is	much	246 
higher	 than	 studies	 of	 other	 types	 of	 travellers	 [7,17,20,21]	 and	 consistent	with	 previous	247 
surveys	of	backpackers	[22].	Previous	studies	of	HBV	vaccination	amongst	travellers	have	not	248 
consistently	reported	dose	number,	but	the	rate	of	protection	against	HBV	(previous	infection	249 
or	completed	vaccination	scheme	[15])	in	this	study	is	lower	than	in	the	findings	of	a	European	250 
Airport	Survey	(30%	vs.	44%)	[21].	In	the	present	study,	two-thirds	of	the	participants	who	251 
took	part	in	high-risk	activities	were	vulnerable	to	developing	HBV,	as	they	had	not	completed	252 
a	vaccination	scheme	or	acquired	immunity	from	previous	infection:	this	is	a	larger	proportion	253 
than	in	studies	of	other	types	of	travellers	to	high	endemicity	countries	[8,17,19].		254 
1.4.3	Strengths	&	Limitations	255 
Previous	studies	on	HBV	exposure	amongst	travellers	have	been	conducted	either	via	256 
airport	 surveys	 [21],	or	by	online	 [19,23,24]	or	postal	questionnaires	 [25].	 The	online	and	257 
postal	recruitment	methods	had	low	response	rates	and	a	large	proportion	of	respondents	258 
had	 not	 visited	 countries	 with	 endemic	 HBV	 [19,23,24,25].	 Airport	 surveys	 calculated	259 
exposure	 risk	based	on	behaviour	on	previous	 journeys:	 this	assumes	similar	behaviour	 in	260 
various	destinations	and	on	different	types	of	holidays	[21].	In	contrast,	the	present	study	had	261 
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a	much	higher	response	rate	and	participants	were	recruited	in	an	endemic	country	and	asked	262 
about	their	behaviour	on	their	current	trip.		263 
Data	were	collected	over	two	months	on	two	islands	in	Thailand	and	so	may	not	be	264 
representative	of	 backpackers	 year-round	across	 the	whole	of	 Thailand	or	of	 backpackers	265 
visiting	 other	 countries	 in	 South	 East	 Asia.	 Due	 to	 the	 study	 design,	 causality	 cannot	 be	266 
inferred	from	the	results.	123	(7%)	of	the	completed	questionnaires	were	unusable	due	to	an	267 
electronic	 data	 file	 corruption,	 but	 this	 is	 unlikely	 to	 have	 introduced	 a	 source	 of	 bias	268 
considering	 the	 large	 sample	 size.	Participants	were	 selected	using	 convenience	 sampling,	269 
which	could	be	a	source	of	bias.	However,	all	visitors	to	the	islands	had	to	leave	by	ferry	and	270 
the	researchers	systematically	approached	all	 individuals	at	the	ferry	port	to	minimise	this	271 
bias.	A	further	limitation	of	the	study	is	that	sexual	preferences	were	not	considered:	men	272 
who	have	sex	with	men	are	known	to	have	an	increased	risk	of	HBV	[26].	In	accordance	with	273 
the	University	of	Birmingham	policy,	participants	from	the	United	States	had	to	be	excluded.	274 
The	 survey	was	 only	 available	 in	 English,	 due	 to	 time	 limitations,	 therefore	 also	 excluded	275 
those	unable	to	read	English.	Collectively	 this	 limits	 the	generalizability	of	 the	results.	The	276 
sample	 was	 largely	 made	 up	 of	 European	 residents,	 which	 in	 conjunction	 with	 the	277 
requirement	to	understand	English,	may	bias	the	results.	However,	an	ethnographical	study	278 
of	backpackers	found	that	backpackers	are	typically	of	Western	origin	and	have	a	higher	level	279 
of	education	than	the	general	level	in	their	country	[27].	There	was	no	significant	difference	280 
in	risk	taking	behaviours	between	backpackers	of	European	and	non-European	origins.	281 
1.4.4	Clinical	Implications	282 
Non-immune	 individuals	who	 partake	 in	 high-risk	 activities	whilst	 visiting	 endemic	283 
countries	are	at	risk	of	developing	hepatitis	B;	in	the	UK	twelve	percent	of	acute	HBV	cases	in	284 
the	UK	reported	overseas	travel	during	the	 incubation	period	[28].	Contracting	HBV	whilst	285 
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travelling	has	consequences	not	 just	 for	 the	 individual	but	also	 for	 their	close	contacts	on	286 
return	home	and	 the	healthcare	 system	of	 their	 country	of	 origin.	One	 in	 twenty	healthy	287 
adults	 who	 contract	 HBV	will	 develop	 a	 persistent	 infection	 and	 become	 chronic	 carriers	288 
capable	 of	 transmitting	 the	 virus	 [29].	 	 Persistent	 infection	 is	 often	 asymptomatic	 but	 is	289 
associated	 with	 late	 stage	 complications	 such	 as	 chronic	 hepatitis,	 cirrhosis	 and	290 
hepatocellular	carcinoma	that	can	be	complex	and	expensive	to	treat	[30,	31].		291 
The	World	Health	Organisation	recommends	universal	vaccination	and	this	has	been	292 
implemented	by	22	of	the	29	European	Union	countries	but	the	UK	has	opted	for	a	selected	293 
vaccination	 scheme	 [9].	 	 UK	 guidelines	 state	 that	 ‘at-risk’	 travellers	 to	 endemic	 countries	294 
should	be	vaccinated	and	that	the	HCP	should	make	an	assessment	of	the	risk	depending	on	295 
the	duration	of	travel,	planned	activities	and	the	destination’s	HBV	prevalence	[10].		A	fifth	of	296 
the	present	study	sample	was	from	the	UK	and	of	these	approximately	thirty	per	cent	were	297 
fully	vaccinated	against	HBV;	there	was	no	association	between	vaccination	against	HBV	and	298 
participation	 in	 high	 HBV	 exposure	 risk	 activities.	 Given	 the	 low	 level	 of	 immunisation	299 
amongst	 the	UK	participants	 in	 the	 present	 study	 and	 the	 failure	 to	 immunise	 the	 at-risk	300 
population	 it	 is	 recommended	 that	 UK	 immunisation	 guidelines	 are	 revised	 to	 consider	301 
vaccination	of	all	backpackers	travelling	to	Thailand	and	South	East	Asia.		302 
For	a	vaccination	schedule	to	be	completed,	consultation	with	a	HCP	needs	to	occur	303 
at	least	2	months	prior	to	departure;	for	this	to	occur	the	individual	must	be	aware	of	the	304 
need	 to	 visit	 a	 HCP	 and	 consult	 well	 in	 advance	 of	 their	 trip.	 The	 increased	 risk	 of	 HBV	305 
exposure	in	this	population	was	mainly	attributable	to	participation	in	voluntary	risk	activities	306 
and	this	should	be	considered	during	the	pre-travel	health	consultation.	Backpackers	should	307 
be	advised	about	practising	safe	sex	and	taught	about	the	risks	of	unsterile	needles	and	the	308 
need	for	good	hygiene	standards	in	tattoo	parlours	alongside	vaccination	advice.	Condom	use	309 
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should	also	help	to	aid	the	control	of	other	STDs	and	the	avoidance	of	unwanted	pregnancy.	310 
Further	research	is	needed	to	identify	the	most	effective	method	of	increasing	vaccination	311 
uptake	and	reducing	risk	behaviors	amongst	backpackers.	312 
1.5	Conclusion	313 
Hepatitis	 B	 is	 a	 preventable	 disease	 that	 can	 cause	 acute	 illness	 and	 chronic	314 
complications.	Whilst	 a	 high	 proportion	 of	 backpackers	 in	 Thailand	 seek	 pre-travel	 health	315 
advice,	only	30%	in	our	sample	were	protected	against	HBV	and	20%	placed	themselves	at	316 
high	risk	of	HBV	exposure	due	to	their	behavior	whilst	abroad.	Early	consultation	with	a	HCP	317 
before	 travel	 and	 promotion	 of	 HBV	 vaccination	 are	 required	 to	 bolster	 the	 rates	 of	318 
protection.		Furthermore,	backpackers	could	benefit	from	sexual	health	advice	and	the	risks	319 
of	body	modification	whilst	abroad	in	order	to	reduce	their	risk	of	contracting	hepatitis	B.		320 
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